|
2006 Conference Publication Prevalence of primary aldosteronism among Chinese hypertensive patientsGong, Y., Zhu, D., Zhang,, Chen, S. L., Chu, S.X., Zhang, L.H., Stowasser, M. and Gordon, R. D. (2006). Prevalence of primary aldosteronism among Chinese hypertensive patients. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15th to 19th October, 2006. Japan: International Society of Hypertension. |
|
2006 Conference Publication Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronismKostner, K., Liu, Y., Cowley, D. and Stowasser, M. (2006). Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism. ISA 2006: XIV International Symposium on Atherosclerosis, Rome, Italy, 18-22 June 2006. E. Park, Shannon, Co. Clare, Ireland: Elsevier Ireland. doi: 10.1016/S1567-5688(06)81883-0 |
|
2005 Conference Publication Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindredStowasser, M, Elphinstone, M, So, A, Jeske, Y and Gordon, R (2005). Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. 26th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, Sydney Australia, Nov 24-26, 2004. OXFORD: BLACKWELL PUBLISHING. |
|
2005 Conference Publication Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type IStowasser, Michael, Sharman, James, Leano, Rodel, Gordon, Richard, Ward, Gregory, Cowley, Diane and Marwick, Thomas (2005). Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, CA, USA, 14 - 18 May, 2005. USA: Elsevier Inc. doi: 10.1016/j.amjhyper.2005.03.648 |
|
2005 Conference Publication Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversionStowasser, M, Jeske, Y., So, A., Gordon, R. and Duffy, D. (2005). Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversion. The 26th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Sydney, Australia, 24-26 November, 2004. Oxford: Blackwell Scientific Publications. |
|
2005 Conference Publication Further evidence of linkage at 7p22 with familial hyperaldosteronism type IISo, Albertina, Stowasser, Michael, Gordon, Richard, Duffy, David and Jeske, Yvette (2005). Further evidence of linkage at 7p22 with familial hyperaldosteronism type II. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, USA, 14-18 May 2005. Elsevier Inc: New York, USA. doi: 10.1016/j.amjhyper.2005.03.659 |
|
2005 Conference Publication Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneitySo, A., Stowasser, M., Gordon, R., Duffy, D. and Jeske, Y. (2005). Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity. The 26th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Sydney, Australia, 24-26 November, 2004. Blackwell Scientific Publications: BLACKWELL PUBLISHING. |
|
2005 Conference Publication No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sampleJeske, Y., So, A., Gordon, R. D., Duffy, D. and Stowasser, M. (2005). No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, U.S.A., 14-18 May 2005. New York, U.S.A.: Nature Publishing Group. doi: 10.1016/j.amjhyper.2005.03.012 |
|
2004 Conference Publication Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonismMottram, PM, Haluska, BA, Leano, R, Cowley, D, Stowasser, M and Marwick, TH (2004). Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism. ESC Congress 2004, Munich Germany, Aug 28-Sep 01, 2004. |
|
2004 Conference Publication Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continentsMulatero, P, Stowasser, M, Loh, KC, Fardella, CE, Gordon, RD, Mosso, L, Gomez-Sanchez, CE, Veglio, F and Young, WF (2004). Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. 14th European Meeting on Hypertension, Paris France, Jun 13-17, 2004. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00004872-200406002-00629 |
|
2004 Conference Publication Is primary aldosteronism associated with abnormal myocardial function independent of blood pressure?Stowasser, M, Mottram, P, Leano, R, Klaassen, P, Cowley, D and Marwick, T (2004). Is primary aldosteronism associated with abnormal myocardial function independent of blood pressure?. 30th International Geographical Congress 2004, Glasgow Scotland, Aug, 2004. CARLTON: LIPPINCOTT WILLIAMS & WILKINS. |
|
2004 Conference Publication Reninoma - Carefully performed renal venous renin ratio studies (RVRRS) are critical for diagnosisSo, A, Gordon, RD and Stowasser, M (2004). Reninoma - Carefully performed renal venous renin ratio studies (RVRRS) are critical for diagnosis. 30th International Geographical Congress 2004, Glasgow Scotland, Aug, 2004. CARLTON: BLACKWELL PUBLISHING ASIA. |
|
2004 Conference Publication Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonismMottram, P., Haluska, B. A., Leano, R. L., Cowley, D., Stowasser, M. and Marwick, T. H. (2004). Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism. European Society of Cardiology Congress, Munich, Germany, 28 August - 1 September, 2004. UK: Oxford University Press. |
|
2004 Conference Publication Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonismMottram, Philip M., Haluska, Brian A., Leano, Rodel, Cowley, Dianne, Stowasser, Michael and Marwick, Thomas H. (2004). Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism. The Cardiac Society of Australia and New Zealand, New Zealand Annual Scientific Meeting 2004 Cardiology Bench to Bedside: The Science and The Practice, Brisbane, Australia, 7 - 11 August, 2004. Australia: Blackwell Publishing Asia. doi: 10.1016/j.hlc.2004.05.001 |
|
2004 Conference Publication The rebirth of primary aldosteronismStowasser, M., Gordon, R., Duffy, D., Rutherford, J., So, A. and Jeske, Y. (2004). The rebirth of primary aldosteronism. 12th International Congress of Endocrinology, Lisbon Portugal, August 31-September 4 2004. Bologna, Italy: Medimond. |
|
2004 Conference Publication Familial hyperaldosteronism type II (FH-II) is more common than type I (FH-I) and demonstrates linkage to chromosome 7p22Stowasser, M, Gordon, R. D., Elphinstone, M. S. and So, A (2004). Familial hyperaldosteronism type II (FH-II) is more common than type I (FH-I) and demonstrates linkage to chromosome 7p22. 20th Scientific Meeting of the International Society of Hypertension, Sao Paulo, Brazil, 15-19 February 2004. London, UK: Lipincott Williams & Wilkins. doi: 10.1097/00004872-200402001-00702 |
|
2004 Conference Publication Primary aldosteronism: a common cause of hypertension with a genetic basisStowasser, Michael, So, Albertina and Gordon, Richard (2004). Primary aldosteronism: a common cause of hypertension with a genetic basis. 18th World Congress: International Society for Heart Research, Brisbane, QLD Australia, 7-11 August 2004. London, United Kingdom: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003 |
|
2003 Conference Publication Some evidence for a chronic (but not acute) effect of aldosterone on procollagen levels in humansStowasser, M., Klaassen, P., Gunasekera, T. G., Cowley, D. C. and Gordon, R. D. (2003). Some evidence for a chronic (but not acute) effect of aldosterone on procollagen levels in humans. 24th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Melbourne, Australia, 25–29 November 2002. Oxford, U.K: Blackwell Scientific Publications. doi: 10.1046/j.1440-1681.2003.d01-2.x |
|
2003 Conference Publication Safety and efficacy of sildenafil citrate in men with erectile dysfunction and hypertension who are taking multiple antihypertensive treatmentsPuddey, IB, Sutherland, P, McLachlan, R, Pollock, C, Stowasser, M, Mancia, G and Pickering, TG (2003). Safety and efficacy of sildenafil citrate in men with erectile dysfunction and hypertension who are taking multiple antihypertensive treatments. 24th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Melbourne, Australia, 25-29 November 2002. Oxford, UK: Blackwell. doi: 10.1046/j.1440-1681.2003.d01-2.x |
|
2003 Conference Publication Primary aldosteronism is associated with abnormal myocardial function independent of blood pressureStowasser, Michael, Mottram, Philip, Leano, Rodel L., Klaassen, Paul, Cowley, Dianne and Marwick, Thomas H. (2003). Primary aldosteronism is associated with abnormal myocardial function independent of blood pressure. American Heart Association 2003 Scientific Sessions, Orlando, USA, 9th - 12th November, 2003. Baltimore, USA: Lippincott Williams & Wilkins. |
